Skip to main content Back to Top
Advertisement

11/23/2021

Olanzapine Intramuscular Injection

Products Affected - Description

    • Olanzapine intramuscular injection, American Regent, 10 mg, vial, 1 count, NDC 00517-0955-01
    • Olanzapine intramuscular injection, AuroMedics, 10 mg, vial, 1 count, NDC 55150-0308-01
    • Olanzapine intramuscular injection, Sandoz, 10 mg, vial, 1 count, NDC 00781-3159-72

Reason for the Shortage

    • American Regent did not provide a reason for the shortage.
    • AuroMedics did not provide a reason for the shortage.
    • Sandoz did not provide a reason for the shortage.

Available Products

    • Zyprexa intramuscular injection, Lilly USA, LLC, 10 mg, vial, 1 count, NDC 00002-7597-01

Estimated Resupply Dates

    • American Regent has olanzapine 10 mg vials available in limited supply.
    • AuroMedics has olanzapine 10 mg vials on intermittent back order and the company is releasing product as it becomes available.
    • Sandoz has olanzapine 10 mg vials on back order and the company estimates a release date of mid- to late-December 2021.

Updated

Created November 23, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.